{"id":95811,"date":"2026-09-16T06:13:31","date_gmt":"2026-09-16T10:13:31","guid":{"rendered":"https:\/\/hedgeco.net\/news\/09\/2026\/apollo-and-kkr-closed-a-e3-billion-capital-solution-for-bayers-larc-business.html"},"modified":"2026-09-16T06:13:31","modified_gmt":"2026-09-16T10:13:31","slug":"apollo-and-kkr-closed-a-e3-billion-capital-solution-for-bayers-larc-business","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/09\/2026\/apollo-and-kkr-closed-a-e3-billion-capital-solution-for-bayers-larc-business.html","title":{"rendered":"Apollo and KKR Closed a \u20ac3 Billion Capital Solution for Bayer\u2019s LARC Business:"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/hedgeco.net\/news\/wp-content\/uploads\/2026\/09\/2026-09-16-bayer-hero.jpg\" alt=\"Apollo and KKR Closed a \u20ac3 Billion Capital Solution for Bayer\u2019s LARC Business:\" \/><\/p>\n<p>HedgeCo.Net \u2014 Apollo announced on September 16 that Apollo-managed funds and affiliates have successfully closed a \u20ac3 billion capital solution for Bayer that was previously announced on July 10, with KKR joining as a significant minority participant, according to Apollo\u2019s close release as carried on Market Newsdesk and StockTitan and consistent with Bayer\u2019s July 10 structure disclosure. Under the transaction, Apollo together with KKR invested equity capital into a newly established entity holding Bayer\u2019s long-acting reversible contraceptives (LARC) business. Bayer retains a majority stake in the entity and continues to exercise full operational control; the company said there are no changes to the LARC strategy as a result of the investment.<\/p>\n<p>Bayer\u2019s July announcement framed the \u20ac3.0 billion equity capital as a balance-sheet \/ capital-structure solution while keeping LARC inside the Pharmaceuticals Division and fully consolidated. Apollo described the deal through its High Grade Capital Solutions platform as large, flexible, bespoke capital to a blue-chip corporate. Advisors on the July tape included BofA Securities and Deutsche Bank for Bayer and Linklaters; Apollo counsel included Latham &#038; Watkins, Paul Weiss, and NautaDutilh.<\/p>\n<p>This is a closed capital-solutions equity investment, not a full carve-out sale of control. Mark the \u20ac3 billion size, the Sep 16 close, KKR\u2019s significant minority participation, Bayer\u2019s majority stake and full operational control, and the LARC perimeter as sourced. Do not invent KKR\u2019s exact check size, an IRR, leverage terms, or a regulatory-clearance chronology beyond the closed status on the Apollo tape. The allocator object is a sponsor-led minority capital solution into a ring-fenced pharma cash-flow perimeter with the corporate retaining ops control.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>HedgeCo.Net \u2014 Apollo announced on September 16 that Apollo-managed funds and affiliates have successfully closed a \u20ac3 billion capital solution for Bayer that was previously announc\u2026 <a class=\"continue_reading_link btn btn-mini\" href=\"https:\/\/hedgeco.net\/news\/09\/2026\/apollo-and-kkr-closed-a-e3-billion-capital-solution-for-bayers-larc-business.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":8,"featured_media":95810,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16384],"tags":[7725,19498,19500,4119,19499,19501],"class_list":["post-95811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-private-credit","tag-apollo","tag-bayer","tag-capital-solutions","tag-kkr","tag-larc","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/95811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=95811"}],"version-history":[{"count":0,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/95811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media\/95810"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=95811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=95811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=95811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}